Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459056 · ClinicalTrials.gov registry record · Phase 3
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
A Phase 3 study, sponsored by St. Paul Heart Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT00459056 is a Phase 3 study that has completed, run by St. Paul Heart Clinic. The registered enrollment target is 25 participants.
The verdict
NCT00459056, a Phase 3 study, has completed, sponsored by St. Paul Heart Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of two different combination therapies for high blood pressure on vascular health.
Interventions
- DRUG Carvedilol CR + Lisinopril
- DRUG Lisinopril + HCTZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00459056
The ClinicalTrials.gov registry entry for NCT00459056 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Paul Heart Clinic, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carvedilol CR + Lisinopril is the first listed.
NCT00459056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00459056 about?
NCT00459056 is a clinical study titled "The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients". The purpose of this study is to compare the effects of two different combination therapies for high blood pressure on vascular health.
What is the current status of trial NCT00459056?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2007-04. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00459056?
The interventions under investigation include: Carvedilol CR + Lisinopril (DRUG), Lisinopril + HCTZ (DRUG).
Who is sponsoring clinical trial NCT00459056?
This trial is sponsored by St. Paul Heart Clinic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.